Seventh Sense Biosystems Adds $4.5M
Cambridge, Mass.-based Seventh Sense Biosystems has raised $4.5 million of a planned $10 million Series A round, the company said Wednesday. Existing investors Flagship Ventures, Polaris Venture Partners and Third Rock Ventures provided the tranche, which will be used for continued development of the company’s blood sampling technology.
11 May 2011•2 mins read
